Metraipolis › archive › dc_fe0ddc22142e
Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy — Europe PMC PMID:41009791
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41009791
- DOI
- 10.3390/ijms26189230
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T20:20:23.237Z
- SHA-256 of the archived text
bf4ff019fb8b0ec9ab190495f9fb64d500d0028ee60dd7eb8a717726d79fb467- Stable URL of this page
https://metraipolis.com/documento/dc_fe0ddc22142e
How to cite
Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy — Europe PMC PMID:41009791 — Europe PMC (en), https://europepmc.org/article/MED/41009791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe0ddc22142e (Metraipolis archive dc_fe0ddc22142e, sha256 bf4ff019fb8b0ec9ab190495f9fb64d500d0028ee60dd7eb8a717726d79fb467)
BibTeX
@misc{dcfe0ddc22142e,
title = {Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy — Europe PMC PMID:41009791},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41009791},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe0ddc22142e; sha256 bf4ff019fb8b0ec9ab190495f9fb64d500d0028ee60dd7eb8a717726d79fb467},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41009791. Agents can read the archived copy with the MCP tool read_document.